Key facts
- This page summarizes Sabina Rizvi's Form 3 filing for MusclePharm Corp.
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 28 Jul 2022, 16:15.
Sabina Rizvi - 01 Apr 2021 Form 3 Insider Report for MusclePharm Corp
- Reporting relationship
- President & CFO
- Issuer ticker
- N/A
- Reported as of
- 01 Apr 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 28 Jul 2022, 16:15:37 UTC
- Next SEC filing
- 28 Jul 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sabina Rizvi
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sabina Rizvi filed Form 3 for MusclePharm Corp on 28 Jul 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MSLP
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 01 Apr 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.